DPIIT recognised startup Government of India
Startup India
Eris Bionxt Private Limited - pharma in Goharganj, Madhya Pradesh, India. FY 2026 financials & compliance.
Authorised capital
₹15 Cr
Registered with MCA
Paid-up capital
₹14.31 Cr
Issued & subscribed
Satisfied charges
₹73.5 Cr
No open charges
Company age
6 yrs
Est. 2020
Employees · EPFO
116
Provident fund records
Directors on board
3
As per MCA filings
Active GSTINs
2
GST registered
Last financials
Mar 2024
Balance sheet date
About Eris Bionxt Private Limited
Data last updated:
Eris Bionxt Private Limited is a private limited company based in Goharganj, Madhya Pradesh, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24299MP2020PTC051505. Its GSTIN is 23AACCW6604K1ZB (Madhya Pradesh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹14.31 Cr. It is led by directors including Inderjeet Singh Negi and Kaushal Kamlesh Shah.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Goharganj, Madhya Pradesh.
The company has about 116 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹73.5 Cr on record. The company has 2 deals on record (1 funding round, 1 rights issue), with disclosed funding of ₹9.85 Cr; the latest was in March 2022. Its 5 peer companies in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger; the largest is Brigid Remedies Private Limited with revenue of ₹10.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website wyzonbiotics.com.
Company details
CIN U24299MP2020PTC051505
Registration Number 051505
Incorporation Date 15 June 2020
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Recognitions & Rankings of Eris Bionxt
Contact details
Eris Bionxt Private Limited's registered office is in Goharganj, Madhya Pradesh. Its website is wyzonbiotics.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressKhasra No. 58/1 58/2 Bishankheda (Obedullaganj) Near Mandideep Industrial Area Hoshanga, Bad Road, Goharganj, Madhya Pradesh, India – 464993
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Eris Bionxt Private Limited, buy the company report.
Comprehensive company report
Eris Bionxt Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Eris Bionxt is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Eris Bionxt Private Limited, buy the company report.
Financials of Eris Bionxt Private Limited
FY 2024 filings availableEris Bionxt Private Limited reported revenue of ₹0 (down 87% YoY) for FY 2025.
Revenue · FY 2025
₹0 ▼ 87%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 87%
Revenue fell 87% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Eris Bionxt Private Limited, buy the company report.
Board of directors of Eris Bionxt Private Limited
Eris Bionxt has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Inderjeet Singh Negi Also directs: Eris Lifesciences Limited, Eris Healthcare Private Limited, Eris Therapeutics Limited and 3 more | Director | 13 Sep 2024 | 2 Years 1 Months | Current |
| Kaushal Kamlesh Shah Also directs: Eris Lifesciences Limited, Eris Healthcare Private Limited, Eris Therapeutics Limited and 5 more | Director | 13 Sep 2024 | 2 Years 1 Months | Current |
| Sachin Shah Also directs: Eris Healthcare Private Limited, Eris Therapeutics Limited, Aprica Healthcare Limited and 4 more | Director | 13 Sep 2024 | 2 Years 1 Months | Current |
Peer comparison
Eris Bionxt Private Limited is compared with the 5 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Brigid Remedies Private Limited | ₹10 (FY 2024) | Bangalore, Karnataka, India | ||||
| Medaffirm Pharmaceuticals Private Limited | ₹9 (FY 2022) | Mumbai, Maharashtra, India | ||||
| Abrar India Chemicals Private Limited | ₹5 (FY 2025) | -100.0% | Panvel, Maharashtra, India | |||
| Leaf2life Wellness Industries Private Limited | ₹2 (FY 2022) | Delhi, India | ||||
| Janshiswati Homeo Laboratory (OPC) Private Limited | ₹1 (FY 2025) | Dumka, Jharkhand, India | ||||
| Eris Bionxt Private Limitedthis company | ₹0 (FY 2025) | -87.0% | 116 | Goharganj, Madhya Pradesh, India |
To see the full peer comparison of Eris Bionxt Private Limited, buy the company report.
Auditor
Eris Bionxt Private Limited is audited by JOSHI VINOD AND COMPANY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JOSHI VINOD AND COMPANY | FY 2023 | 004438C |
Shareholding
The shareholding of Eris Bionxt Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Eris Bionxt Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹73.5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Sep 2022 | 100610503 | Others | ₹47.5 Cr | Satisfied | |
| 03 May 2021 | 100447208 | Karnataka Bank Ltd. | ₹26 Cr | Satisfied |
To see the full charge records of Eris Bionxt Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Eris Bionxt Private Limited has 2 deals on record (1 funding round, 1 rights issue), with disclosed funding of ₹9.85 Cr; the latest was in March 2022.
Total deals
2
Funding round
1
Rights issue
1
Disclosed funding
₹9.85 Cr
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Rights issue | ₹4.31 Cr | Investors: 4 individuals |
| Aug 2020 | Funding round | ₹9.85 Cr | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Eris Bionxt Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Eris Bionxt Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Eris Bionxt Private Limited has a workforce of 116 employees on its EPFO records as of Mar 30, 2024, across 1 active EPFO establishment.
Employee count
116
Active EPFO establishments
1
Employee growth
6.42%
GST
Eris Bionxt has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AACCW6604K1ZB | Madhya Pradesh | Active | 17 Jul 2020 |
| 24AACCW6604K1Z9 | Gujarat | Active | 05 Feb 2025 |
To see the full GST registrations and return filing status of Eris Bionxt Private Limited, buy the company report.
Recent activity
Eris Bionxt Private Limited has 11 board changes on record since 2021: 3 appointments and 8 cessations. The latest: Brajesh Sarathe ceased to be Additional Director on 30 Sep 2024.
AGM
Eris Bionxt Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Brajesh Sarathe ceased to be Additional Director.
Ceased
Inderjeet Singh Negi ceased to be Additional Director.
Ceased
Kaushal Kamlesh Shah ceased to be Additional Director.
Ceased
Sachin Shah ceased to be Additional Director.
Charges
A charge registered on 15 Sep 2022 via Charge ID 100610503 with Others was fully satisfied on 20 Sep 2024.
Ceased
Darbar Singh Rajput ceased to be Director.
Appointed
Inderjeet Singh Negi was appointed as Director.
Appointed
Kaushal Kamlesh Shah was appointed as Director.
Ceased
Narendra Rawtani ceased to be Director.
Appointed
Sachin Shah was appointed as Director.
Filing
Eris Bionxt Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior.
8 earlier events are in the company report.
Frequently asked questions
Eris Bionxt is an active private limited company based in Goharganj, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 June 2020 (6+ years old) and is registered under CIN U24299MP2020PTC051505.
Eris Bionxt has 3 current directors:
- Inderjeet Singh Negi - Director
- Kaushal Kamlesh Shah - Director
- Sachin Shah - Director
The latest financial statements of Eris Bionxt on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Eris Bionxt is 23AACCW6604K1ZB, registered in Madhya Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AACCW6604K1Z9 (Gujarat).
The CIN (Corporate Identification Number) of Eris Bionxt is U24299MP2020PTC051505. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eris Bionxt was incorporated on 15 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Gwalior.
Eris Bionxt has 2 deals on record (1 funding round, 1 rights issue), with disclosed funding of ₹9.85 Cr; the latest was in March 2022.
The peers of Eris Bionxt by revenue are Brigid Remedies Private Limited, Medaffirm Pharmaceuticals Private Limited, Abrar India Chemicals Private Limited, Leaf2life Wellness Industries Private Limited, Janshiswati Homeo Laboratory (OPC) Private Limited, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Brajesh Sarathe ceased to be Additional Director on 30 Sep 2024. Inderjeet Singh Negi ceased to be Additional Director on 29 Sep 2024. Kaushal Kamlesh Shah ceased to be Additional Director on 29 Sep 2024. Eris Bionxt has 11 board changes on record in total.
Yes, Eris Bionxt is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Eris Bionxt can be reached through the website wyzonbiotics.com. Its registered office is in Goharganj, Madhya Pradesh, India.